Scott Sherman, M.D., Ph.D., and Torsten Falk, Ph.D., both associate professors in the University of Arizona College of Medicine – Tucson, have developed a method of using ketamine in the treatment of Parkinson’s disease. The university has entered into an exclusive licensing agreement with Pharmather Inc., a subsidiary of… Read more »